Literature DB >> 10963722

Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy.

P Hardy1, I Dumont, M Bhattacharya, X Hou, P Lachapelle, D R Varma, S Chemtob.   

Abstract

The choroid is the main source of oxygen to the retina. In contrast to the adult, the absence of autoregulation of choroidal blood flow in the newborn leads to hyperoxygenation of the retina. In the immature retina which contains relatively low levels of antioxidants this hyperoxygenation favors peroxidation including the generation of biologically active isoprostanes, and results in vasoconstriction and vascular cytotoxicity leading to ischemia, which predisposes to the development of a vasoproliferative retinopathy, commonly termed retinopathy of prematurity. During frequently encountered oxidative stress to the perinate, the combined absence of vascular autoregulation and excessive oxygen delivery to the eyes of the developing subject is largely the result of a complex epigenetic and genetic interplay between prostanoids and nitric oxide (NO) systems on vasomotor regulation. The effects of certain prostaglandins are NO-dependent; conversely, those of NO have also been found to be largely prostaglandin I(2)-mediated in the eye; and NO synthase expression seems to be significantly regulated by other prostaglandins apparently through activation of functional perinuclear prostanoid receptors which affect gene transcription. The increased production of both prostaglandins and NO in the perinate augment ocular blood flow and as a result oxygen delivery to an immature retina partly devoid of antioxidant defenses. The ensuing peroxidation results in impaired circulation (partly thromboxane A(2)-dependent) and vascular integrity, leading to ischemia which predisposes to abnormal preretinal neovascularization, a major feature of ischemic retinopathy. Because tissue oxygenation is largely dependent upon circulation and critical in the generation of reactive oxygen species, and since the latter exert a major contribution in the pathogenesis of retinopathy of prematurity, it is important to understand the mechanisms that govern ocular blood flow. In this review we focus on the important and complex interaction between prostanoid, NO and peroxidation products on circulatory control of the immature retina.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963722     DOI: 10.1016/s0008-6363(00)00084-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  32 in total

1.  Predicting gene ontology biological process from temporal gene expression patterns.

Authors:  Astrid Lagreid; Torgeir R Hvidsten; Herman Midelfart; Jan Komorowski; Arne K Sandvik
Journal:  Genome Res       Date:  2003-04-14       Impact factor: 9.043

2.  The age-dependent decrease in the myogenic response of retinal arterioles as studied with the Retinal Vessel Analyzer.

Authors:  Peter Jeppesen; Pernille A Gregersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-17       Impact factor: 3.117

Review 3.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

4.  Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension.

Authors:  Joshua P Fessel; Ned A Porter; Kevin P Moore; James R Sheller; L Jackson Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

5.  MnTBAP or Catalase Is More Protective against Oxidative Stress in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia than Their Co-Administration (EUK-134).

Authors:  Michelle Quan; Charles L Cai; Gloria B Valencia; Jacob V Aranda; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2017-01-01

6.  Nitric oxide and octreotide in retinal ischemia-reperfusion injury.

Authors:  Ulku Celiker; Necip Ilhan
Journal:  Doc Ophthalmol       Date:  2002-11       Impact factor: 2.379

7.  Possible influences of lutein and zeaxanthin on the developing retina.

Authors:  J Paul Zimmer; Billy R Hammond
Journal:  Clin Ophthalmol       Date:  2007-03

8.  ADAM9 is involved in pathological retinal neovascularization.

Authors:  Victor Guaiquil; Steven Swendeman; Tsunehiko Yoshida; Sai Chavala; Peter A Campochiaro; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

Review 9.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

Review 10.  The development of the rat model of retinopathy of prematurity.

Authors:  Joshua M Barnett; Susan E Yanni; John S Penn
Journal:  Doc Ophthalmol       Date:  2009-07-29       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.